Early Lung Cancer detection with a simple blood test
Our CIZ1B biomarker test is a non-invasive, cost effective breakthrough for detecting lung cancer at its earliest stages.
DETECT EARLY. SAVE LIVES.
Meeting the Challenge for Early Cancer Detection with simple blood tests
Cizzle Biotech is developing a solution for a cost effective and an earlier way to detect lung cancer and reduce the need for repeated CT scanning.
A Simple Blood Test
A LIFE SAVING BREAKTHROUGH
Cizzle is transforming lung cancer survival by empowering healthcare professionals and patients to enable curative medical intervention using a groundbreaking and affordable diagnostic blood test that can detect lung cancer early.
The Early Detection Challenge
Lung cancer is the leading cause of cancer-related deaths, claiming nearly 5,000 lives daily. The challenge? It’s often silent and symptomless until it’s too late for effective treatment.
Current screening methods rely on CT scans, which have high false positive rates, leading to delayed treatment and unnecessary, costly, and invasive procedures.
We’re redefining the cancer care pathway.
A Simple Solution for a Complex Challenge
Transforming lung cancer detection with a simple, affordable, non-invasive blood test that identifies lung cancer at its earliest stages. Enabling swift, curative action and improving patient outcomes worldwide.
Powered by our highly accurate, proprietary CIZ1B biomarker technology, our test streamlines the diagnostic cancer pathway, improving access to life-saving care. The result? Earlier detection. More treatment options. Better survival rates – giving patients and healthcare providers the power to act early.
One test. Earlier detection. More lives saved.
Transformative Science
Transformative Science
Early Detection – Identifies cancer long before symptoms appear using an advanced immunoassay for the CIZ1B biomarker.
95% Sensitivity – Detects lung cancer early when treatment is most effective
Non-Invasive & Simple – A simple blood test
Reliable & Accurate – Precision diagnostics for confident decision-making
Eliminates Unnecessary Procedures – Reducing invasive follow-ups
Scientific Expertise – Backed by leading researchers at the University of York
Global Impact
Affordable & Accessible – Cost-effective and available to everyone
Patent Protection – Safeguarding our innovative technology
Clinical Trials – Conducting clinical trials globally
Regulatory Pathway – Advancing toward regulatory approval for global adoption
Publicly Listed – Trading on the London Stock Exchange
